Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 1

Interventions

pembrolizumab 606Cyclophosphamide 546Magnetic Resonance Spectroscopy 527Radiotherapy 514Specimen Handling 506Nivolumab 412Cisplatin 381Carboplatin 369Biopsy 306Blood Specimen Collection 304Radiosurgery 290Paclitaxel 281Gemcitabine 271Surveys and Questionnaires 270Standard of Care 267Drug Therapy 264fludarabine 263Dexamethasone 263Bevacizumab 253venetoclax 251Oxaliplatin 209Capecitabine 201Rituximab 199Radiation 192Fluorouracil 189Ipilimumab 188durvalumab 185Doxorubicin 179Etoposide 177atezolizumab 175

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × BKT140 × 1 year × Clear all
NCT07101445 2026-02-10

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

Emory University

Phase 4 Recruiting
94 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡